有创与无创颅内压监测方法评估脑自动调节功能
本研究回顾性分析24例成人脑损伤患者,同时采集有创颅内压(脑室外引流)和无创颅内压(机械延伸计Brain4Care)波形,计算基于10秒平均的AMP或nAMP与MAP的移动相关系数PAx和nPAx。结果PAx与nPAx强相关(R=0.70,p<0.0005,95%CI 0.687-0.717),Bland-Altman分析显示一致性极好,偏倚-0.018(95%CI -0.026至-0.01)。作者认为无创方法可计算PAx,值得进一步研究该工具以早期治疗干预改善急性脑损伤后的神经功能结局。
要点
- 在24例成人脑损伤患者中,有创PAx与无创nPAx强相关(R=0.70,p<0.0005,95%CI 0.687-0.717)。
- Bland-Altman分析显示两种方法一致性极好,偏倚-0.018(95%CI -0.026至-0.01),局部回归趋势线未偏离0。
- PAx和nPAx分别计算为AMP或nAMP的10秒平均值与MAP的移动相关系数,AMP/nAMP取10秒窗内ICP/nICP信号基频振幅,每10秒更新。
- 患者中颅内出血占84%,87.5%接受机械通气,60%镇静,中位GCS 8分(7-15)。
- 作者认为需进一步研究该临床工具,目标是通过早期治疗干预改善急性脑损伤后的神经功能结局。
适用人群与场景
- 成人脑损伤患者,同时行动脉血压监测;颅内出血占84%。
- 87.5%接受机械通气,60%镇静,中位GCS 8分(7-15)。
研究设计与关键结果
- 回顾性分析24例成人脑损伤患者,同时采集有创ICP(脑室外引流)和无创ICP(机械延伸计Brain4Care Corp.)波形数据。
- PAx和nPAx计算为AMP或nAMP的10秒平均值与MAP的移动相关系数;AMP/nAMP取10秒窗内ICP/nICP信号基频振幅,每10秒更新。
- 平均PAx为0.0296±0.331,nPAx为0.0171±0.332。
- PAx与nPAx强相关:R=0.70,p<0.0005,95%CI 0.687-0.717。
- Bland-Altman分析显示一致性极好:偏倚-0.018(95%CI -0.026至-0.01),局部回归趋势线未偏离0。
- 中位年龄53.5岁(四分位距40-70)。
证据类型、等级与局限
- 研究类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,PAx可通过传统和有创ICP监测计算,无创方法与之强相关且一致性极好,值得进一步研究该临床工具,目标是通过早期治疗干预改善急性脑损伤后的神经功能结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pulse amplitude index (PAx), a descriptor of cerebrovascular reactivity, correlates the changes of the pulse amplitude of the intracranial pressure (ICP) waveform (AMP) with changes in mean arterial pressure (MAP). AMP relies on cerebrovascular compliance, which is modulated by the state of the cerebrovascular reactivity. PAx can aid in prognostication after acute brain injuries as a tool for the assessment of cerebral autoregulation and could potentially tailor individual management; however, invasive measurements are required for its calculation. Our aim was to evaluate the relationship between noninvasive PAx (nPAx) derived from a novel noninvasive device for ICP monitoring and PAx derived from gold standard invasive methods.
METHODS: We retrospectively analyzed invasive ICP (external ventricular drain) and non-invasive ICP (nICP), via mechanical extensometer (Brain4Care Corp.). Invasive and non-invasive ICP waveform morphology data was collected in adult patients with brain injury with arterial blood pressure monitoring. The time series from all signals were first treated to remove movement artifacts. PAx and nPAx were calculated as the moving correlation coefficients of 10-s averages of AMP or non-invasive AMP (nAMP) and MAP. AMP/nAMP was determined by calculating the fundamental frequency amplitude of the ICP/nICP signal over a 10-s window, updated every 10-s. We then evaluated the relationship between invasive PAx and noninvasive nPAx using the methods of repeated-measures analysis to generate an estimate of the correlation coefficient and its 95% confidence interval (CI). The agreement between the two methods was assessed using the Bland-Altman test.
RESULTS: Twenty-four patients were identified. The median age was 53.5 years (interquartile range 40-70), and intracranial hemorrhage (84%) was the most common etiology. Twenty-one (87.5%) patients underwent mechanical ventilation, and 60% were sedated with a median Glasgow Coma Scale score of 8 (7-15). Mean PAx was 0.0296 ± 0.331, and nPAx was 0.0171 ± 0.332. The correlation between PAx and nPAx was strong (R = 0.70, p < 0.0005, 95% CI 0.687-0.717). Bland-Altman analysis showed excellent agreement, with a bias of - 0.018 (95% CI - 0.026 to - 0.01) and a localized regression trend line that did not deviate from 0.
CONCLUSIONS: PAx can be calculated by conventional and noninvasive ICP monitoring in a statistically significant evaluation with strong agreement. Further study of the applications of this clinical tool is warranted, with the goal of early therapeutic intervention to improve neurologic outcomes following acute brain injuries.
参考来源
- Hassett CE, Uysal SP, Butler R, et al. Assessment of Cerebral Autoregulation Using Invasive and Noninvasive Methods of Intracranial Pressure Monitoring. Neurocrit Care. 2022. PMID: 36050535. doi:10.1007/s12028-022-01585-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。